October 21, 2017 4:00 PM ET


Company Overview of TELA Bio, Inc.

Company Overview

TELA Bio, Inc. operates in healthcare industry focusing on biotechnology business. The company was founded in 2012 and is based in Malvern, Pennsylvania.

1 Great Valley Parkway

Suite 24

Malvern, PA 19355

United States

Founded in 2012



Key Executives for TELA Bio, Inc.

President and Chief Executive Officer
Age: 51
Compensation as of Fiscal Year 2017.

TELA Bio, Inc. Key Developments

TELA Bio, Inc. Initiates BRAVO Study of OviTex Reinforced BioScaffolds for Hernia Repair

TELA Bio, Inc. announced the company has initiated a post-market clinical study, BioScaffold Reconstruction of Abdominal wall and Ventral hernia defects with Open or laparoscopic repair (BRAVO), of its OviTex™ Permanent 1S device. OviTex RBSs represent the next step in hernia repair, integrating polymer and biologic materials in a unique embroidered construction. The biologic material, derived from ovine rumen, allows for functional tissue remodeling, while the polymer provides additional strength and improved handling. OviTex devices are available with either polypropylene polymer (permanent) or polyglycolic acid polymer (resorbable). TELA Bio commercialized OviTex RBSs in July 2016 and has completed over 400 implantations to-date in a wide range of hernia patients using a variety of surgical techniques. The single-arm, prospective BRAVO study is designed to evaluate the clinical performance of OviTex Permanent 1S in 100 ventral hernia patients. Investigators will initially monitor the incidence of early post-operative surgical site occurrences, wound-related events, and other complications within the first three months following surgery. Further endpoints include the incidence of true hernia recurrence at 90 days, 12 months, and 24 months follow-up and post-operative surgical site occurrences and other complications occurring more than three months after surgery. In addition, patient reported outcomes such as quality of life and pain assessments will also be evaluated. The first patient in the BRAVO study enrolled at Scripps Clinic in La Jolla, California.

TELA Bio, Inc. Presents at 16th Annual Needham Healthcare Conference, Apr-05-2017 09:40 AM

TELA Bio, Inc. Presents at 16th Annual Needham Healthcare Conference, Apr-05-2017 09:40 AM. Venue: Westin Grand Central Hotel, New York, New York, United States. Speakers: Antony Koblish, President and Chief Executive Officer.

TELA Bio, Inc. Announces Settlement of Litigation with LifeCell

TELA Bio, Inc. announced that it has settled all litigations and disputes between TELA Bio and LifeCell, and that all pending state and federal court actions between the two companies have been dismissed.  The settlement will allow TELA Bio to continue to manufacture and sell its OviTex ortfolio of products for use in ventral hernia repair and abdominal wall reconstruction, including a hydrated version of OviTex.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3Bar Biologics Inc. United States

Recent Private Companies Transactions

Private Placement
January 18, 2017

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Tax Management Inc United States
Bertelsmann AG Europe

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact TELA Bio, Inc., please visit www.telabio.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.